Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | ERN1 | O75460 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MPI | P34949 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29957786 | 0.82 | ERN1 (0.57) | TDP1ERN1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL692253 | 0.82 | ERN1 (0.57) | TDP1ERN1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL13825831 | 0.79 | ESR2 (0.57) | TDP1ALDH1A1TSHRNPC1PKM | |
| SCHEMBL18957581 | 0.79 | MAOA (0.46) | TDP1ERN1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL10774187 | 0.79 | CYP3A4 (0.43) | TDP1ALDH1A1CYP3A4POLBKDM4E | |
| SCHEMBL4357334 | 0.78 | TDP1 (0.70) | TDP1ERN1ALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL589945 | 0.77 | CYP3A4 (0.41) | TDP1ALDH1A1CYP3A4POLBKDM4E | |
| SCHEMBL9080019 | 0.77 | CYP3A4 (0.41) | TDP1ALDH1A1CYP3A4POLBKDM4E | |
| SCHEMBL31615190 | 0.77 | CYP3A4 (0.41) | TDP1ALDH1A1CYP3A4POLBKDM4E | |
| SCHEMBL11869494 | 0.76 | ALDH1A1 (0.52) | TDP1ERN1ALDH1A1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-11576946-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | OHIO STATE INNOVATION FOUNDATION (US) | 2023-02-14 | — | — | US | claimed |
| US-20210169966-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2021-06-10 | — | — | US | claimed |
| EP-3749365-A2 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | Ohio State Innovation Foundation (US) | 2020-12-16 | — | — | EP | claimed |
| CN-111892736-A | Polystyrene microsphere for improving sensitivity of latex turbidimetry and preparation method thereof | 上海科华生物工程股份有限公司 | 2020-11-06 | — | — | CN | claimed |
| WO-2019148194-A2 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION (US) | 2019-08-01 | — | — | WO | claimed |
| EP-1235782-B1 | METHOD FOR OXIDATION OF XYLENE DERIVATIVES | GEN ELECTRIC (US) | 2004-02-18 | — | — | EP | claimed |
| US-6465685-B1 | SUCH AS CHLORO-O-XYLENE, ARE OXIDIZED IN A SOLVENT IN THE PRESENCE OF A METAL COMPOUND CATALYST WITH ADDITION OF PROMOTER AFTER THE REACTION HAS PROCEEDED TO AN INTERMEDIATE STAGE; PRODUCT COMPRISES CHLOROPHTHALIC ACID OR ANHYDRIDE | GENERAL ELECTRIC COMPANY | 2002-10-15 | — | — | US | claimed |
| EP-1235781-A1 | METHOD FOR OXIDATION OF XYLENE DERIVATIVES | GENERAL ELECTRIC COMPANY (US) | 2002-09-04 | — | — | EP | claimed |
| EP-1235782-A1 | METHOD FOR OXIDATION OF XYLENE DERIVATIVES | GENERAL ELECTRIC COMPANY (US) | 2002-09-04 | — | — | EP | claimed |
| US-6399790-B1 | USING METAL CATALYST | GENERAL ELECTRIC COMPANY | 2002-06-04 | — | — | US | claimed |
| WO-2001038282-A1 | METHOD FOR OXIDATION OF XYLENE DERIVATIVES | GENERAL ELECTRIC COMPANY (US) | 2001-05-31 | — | — | WO | claimed |
| WO-2001038281-A1 | METHOD FOR OXIDATION OF XYLENE DERIVATIVES | GENERAL ELECTRIC COMPANY (US) | 2001-05-31 | — | — | WO | claimed |
| EP-3573972-B1 | RORGAMMA MODULATORS AND USES THEREOF | GENFIT (FR) | 2026-01-14 | — | — | EP | disclosed |
| US-20250236610-A1 | 3-[(1H-PYRAZOL-4-YL)OXY]PYRAZIN-2-AMINE COMPOUNDS AS HPK1 INHIBITOR AND USE THEREOF | BEIGENE, LTD. (KY) | 2025-07-24 | — | — | US | disclosed |
| EP-4562009-A1 | NOVEL COMPOUNDS | AC Immune SA (CH) | 2025-06-04 | — | — | EP | disclosed |
| US-4153722-A | ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE | WILLIAM H. RORER, INC. (US) | 1979-05-08 | — | — | US | disclosed |
| US-4134917-A | Method for the denitrosation of organic nitrosamines | AMERICAN CYANAMID COMPANY (US) | 1979-01-16 | — | — | US | disclosed |
| US-4126635-A | ANTICHOLESTEROL, BLOOD PLATELET AGGREGATION INHIBITION | A. H. ROBINS COMPANY, INCORPORATED (US) | 1978-11-21 | — | — | US | disclosed |
| US-4045576-A | ANTI-INFLAMMATORY METHODS USING 2-AMINO-3-(5- AND 6-)BENZOYLPHENYLACETIC ACIDS, ESTERS AND METAL SALTS THEREOF AND THE COMPOUNDS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210169966-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | TDP1 3097/4885ERN1 1946/4885ALDH1A1 4853/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | TDP1 3049/4885ERN1 1903/4885ALDH1A1 4851/4885 |
| US-11576946-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | CHP1, NFATC1, PPP3R1 | TDP1 3049/4885ERN1 1903/4885ALDH1A1 4851/4885 |
| US-20250236610-A1 | 3-[(1H-PYRAZOL-4-YL)OXY]PYRAZIN-2-AMINE COMPOUNDS AS HPK1 INHIBITOR AND USE THEREOF | HIPK1, HIPK3, HIPK2 | TDP1 1712/4885ERN1 721/4885ALDH1A1 3156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.